1. Home
  2. BATRA vs LGND Comparison

BATRA vs LGND Comparison

Compare BATRA & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

HOLD

Current Price

$55.20

Market Cap

3.7B

Sector

Industrials

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$297.39

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BATRA
LGND
Founded
1991
1987
Country
United States
United States
Employees
1610
68
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BATRA
LGND
Price
$55.20
$297.39
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$60.00
$256.29
AVG Volume (30 Days)
45.0K
296.1K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.40
$1.25
Revenue Next Year
$8.54
$19.41
P/E Ratio
N/A
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$41.50
$131.67
52 Week High
$58.37
$326.63

Technical Indicators

Market Signals
Indicator
BATRA
LGND
Relative Strength Index (RSI) 45.24 50.82
Support Level $52.23 $290.20
Resistance Level $55.97 $326.63
Average True Range (ATR) 1.13 11.05
MACD -0.33 -3.89
Stochastic Oscillator 15.70 13.07

Price Performance

Historical Comparison
BATRA
LGND

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: